Meta Pixel

News and Announcements

ProofTec launches a pilot with Avis Budget, technology now supports tablet devices

  • Published January 17, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

ProofTec has recently launched a pilot with Avis Budget (NSW South East) across multiple locations.

As part of the pilot, we are excited to announce ProofTec extended the range of supported devices to tablets, in order to leverage the customer’s existing infrastructure and workflow.

Although images captured by tablet cameras are different from what we’re used to on smartphones, the quick extension is a testament to the versatility and robustness of our vision AI technology platform. This paves the way for faster roll-outs with both car rental and car share operators.

We are looking forward to providing them with the great results and service reported by all our other satisfied customers!

Register Interest

About ProofTec

ProofTec provides Damage Attribution – as – a – Service and is focussed on the management of physical assets across a multitude of industries. Our asset condition assessment platform leverages our proprietary AI image processing algorithm to identify both existing and new (incremental) changes to the exterior condition of an asset, across different time-periods.

Prooftec is already backed by Halkin Venture Partners, has been accepted into the CSIRO Kickstarter program, and was picked as one of the winners of the NSW Pitch@Palace 2019.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now